Breath Carbon Monoxide and Cotinine as Biomarkers to Distinguish Smokers From Nonsmokers

NCT01031121 | Completed

• 2 other identifiers: 99990945109-DA-N451
• Study Type: observational
• Target: 240
• Locations: 1 country
• Sites: 1

Brief Summary

Background:

• Self-report and biochemical verification are used to determine smoking status in treatment trials and clinical research. Each method has merits and limitations that make it appropriate for particular situations. Participants who feel social pressure to report tobacco abstinence may provide unreliable self-reporting results. Biochemical verification using breath carbon monoxide (CO) is a more reliable indicator, but several biological and environmental factors (including exposure to secondhand smoke) can affect the sensitivity and specificity of breath CO measurement.
• An ideal biomarker of smoking status is cotinine, the major metabolite of nicotine. Cotinine levels found in blood, urine, and saliva can be used to distinguish between smokers and nonsmokers, as well as between light and heavy smokers. Researchers are interested in using cotinine assessments to develop suitable breath CO cutoff levels to categorize different types of smokers and nonsmokers for use in future research. Objectives: \- To determine a breath carbon monoxide (CO) cutoff level that optimally discriminates between heavy and light smokers and nonsmokers who are and who are not exposed to environmental tobacco smoke. Eligibility:
• Individuals between 18 and 64 years of age who fall into one of the following groups:
• current smokers reporting more than 10 cigarettes per day for at least 6 months
• current smokers reporting 10 or fewer cigarettes per day for at least 6 months
• nonsmokers reporting regular environmental exposure to tobacco smoke
• nonsmokers reporting limited or no exposure to tobacco smoke Design:
• The study will involve a single outpatient session.
• Participants will provide breath CO, urine, and saliva samples, and will complete several smoking-related questionnaires on smoking history, current craving levels, and perceived level of nicotine dependence.

Conditions

Nicotine Dependence

Keywords

Cigarette Smoking; Biomarkers; Nicotine; Cotinine; Metabolites

Eligibility Criteria

• Age: 18 Years - 64 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• For Smokers:
• males and females 18-64 years old
• smoking 1-10 cigarettes or \> 10 cigarettes per day for the past 6 months
• For Nonsmokers:
• \. males and females 18-64 years old

You may not qualify if:

• For Smokers:
• current interest in reducing or quitting smoking
• treatment for nicotine dependence in the past 3 months
• use of nicotine replacement products, bupropion, or varenicline in the past 3 months
• current use of tobacco products other than cigarettes
• marijuana use greater than 5 times in past 14 days or use during 24 hours before session
• chronic pulmonary disease
• study investigator or subordinate staff
• For Nonsmokers:
• use of any tobacco or nicotine products in the past 3 months
• marijuana use greater than 5 times in past 14 days or use during 24 hours before session
• chronic pulmonary disease
• study investigator or subordinate staff

Sponsors & Collaborators

• National Institute on Drug Abuse (NIDA): lead

Study Sites (1)

National Institute on Drug Abuse, Biomedical Research Center (BRC)

Baltimore, Maryland, 21224, United States

Location

Related Publications (3)

• Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect. 1999 May;107 Suppl 2(Suppl 2):349-55. doi: 10.1289/ehp.99107s2349.

  PMID: 10350520 BACKGROUND

• Bernert JT, Harmon TL, Sosnoff CS, McGuffey JE. Use of continine immunoassay test strips for preclassifying urine samples from smokers and nonsmokers prior to analysis by LC-MS-MS. J Anal Toxicol. 2005 Nov-Dec;29(8):814-8. doi: 10.1093/jat/29.8.814.

  PMID: 16374940 BACKGROUND

• Chatkin J, Fritscher L, de Abreu C, Cavalet-Blanco D, Chatkin G, Wagner M, Fritscher C. Exhaled carbon monoxide as a marker for evaluating smoking abstinence in a Brazilian population sample. Prim Care Respir J. 2007 Feb;16(1):36-40. doi: 10.3132/pcrj.2007.00008.

  PMID: 17297525 BACKGROUND

MeSH Terms

Conditions

Tobacco Use Disorder; Cigarette Smoking

Condition Hierarchy (Ancestors)

Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders; Tobacco Smoking; Smoking; Behavior; Tobacco Use

Study Design

• Study Type: observational
• Time Perspective: OTHER
• Sponsor Type: NIH

Study Record Dates

• First Submitted: December 11, 2009
• First Posted: December 14, 2009
• Study Start: June 8, 2009
• Study Completion: October 22, 2010
• Last Updated: July 2, 2017

Record last verified: 2010-10-22

Locations

US (1)